Web-Based Amblyopia Decision Support Tool
May 7, 2026 - 13:44
Radio and PodcastLive Radio & PodcastsInterview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressle...
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab is an episode from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science by American Medical Associat...
This episode belongs to JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science.
Use the player on this page to stream the episode online.
Published Mar 6, 2025, 23:43 long, audio available.
Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema
You can listen to Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab online on Radio and Podcast. Open the player on this page to stream the available audio.
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab is an episode from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science by American Medical Association.
This episode is 23:43 long.
This episode was published on Mar 6, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science when more episodes are available from the podcast feed.
You can listen to Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab on this page when the episode audio is available from the podcast feed.
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab is from JAMA Ophthalmology Author Interviews: Covering research, science, & clinical practice in ophthalmology and vision science by American Medical Association.
Published Mar 6, 2025 and 23:43 long